Mechanism of alerting on cyberattacks practically never used by US — spokespersonWorld May 23, 22:19
Putin praises work of Independent Public Anti-Doping CommissionSport May 23, 20:38
Russia needs expanding representation in global sports federations — ministerSport May 23, 20:21
Russian athletes must be trained for Olympics under certain geographic conditions — PutinSport May 23, 19:38
Final charges brought against Russian ex-economy minister UlyukayevBusiness & Economy May 23, 18:59
WADA delegation to visit Moscow this week to help with membership reinstatementSport May 23, 18:48
US President Donald Trump's first trip abroadWorld May 23, 18:41
Russian scientists master stimulating neurons with infrared irradiationScience & Space May 23, 18:37
Global research team cracks bacteria transmission codes to combat drug-resistant strainsScience & Space May 23, 17:44
REDMOND, Washington, Sept. 10, 2013 /PRNewswire/ -- Worldwide validation for dietary supplement technology that protects probiotics from stomach acid and provides controlled, extended release of live organisms to the intestines. Patents have now been granted in more than 30 countries for Nutraceutix's "Delivery System for Biological Component", trademarked as BIO-tract®. This now includes the 24 countries in the European Patent Convention, in addition to Australia, Canada, Singapore, Japan, Hong Kong, Republic of Korea, People's Republic of China, the Russian Federation and the United States. Additional patents in the U.S. and Canada are pending.
The European Patent Convention includes: Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, The Netherlands, Portugal, Slovakia, Spain, Sweden, Switzerland, Turkey, and the United Kingdom.
Unlike powders, capsules and cultured foods, BIO-tract tablets offer protection from damaging stomach acids, then gently release live organisms over time to the upper and lower intestinal tracts for heightened effectiveness. BIO-tract also takes advantage of Nutraceutix's patented LiveBac® processing to extend probiotic shelf life far beyond other supplemental forms, even at room temperature.
"Our growing, global patent portfolio documents BIO-tract's technical superiority," asserts Tim Gamble, President and CEO of Nutraceutix. "For years, BIO-tract has been a recognized hallmark of quality and is now becoming the industry standard for premium probiotics and other ingredients that benefit from its unique capabilities. It is the only probiotic dietary supplement format that offers such a stellar combination of effective delivery and stability with outstanding formulation and packaging flexibility."
Headquartered in Redmond, Washington, Nutraceutix is an NSF Certified GMP contract manufacturer and private labeler of probiotics and other premium nutritional supplements. The company specializes in producing high-quality probiotics in bulk powder, capsules and tablets from its broad, factory-direct offering of natural probiotic organisms. Nutraceutix's pioneering achievements and unequalled collection of patented processes and technology were recognized by Frost and Sullivan in 2010 with a North American "Technology Innovation of the Year" award.
Nutraceutix Sales and Marketing team